"description","text","uuid:ID","name","label","instanceType","id"
"Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","79361891-be13-4905-b900-2c74ec343598","OBJ1","","OBJECTIVE","Objective_1"
"Safety","To document the safety profile of the xanomeline TTS.","a7060ad1-7fba-4c6c-900b-f73196c29892","OBJ2","","OBJECTIVE","Objective_2"
"Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","a237b21c-9e9a-4692-8430-13714aec4a6c","OBJ3","","OBJECTIVE","Objective_3"
